Trial · NCT04165317
Participant flow35
How many started, completed or left each group, period by period.
1 to 20 of 35
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Phase | STARTED | Cohort A, Arm A: PF-06801591+BCG (IND+MNT) | 352 | |
| Treatment Phase | STARTED | Cohort A, Arm B: PF-06801591+BCG (IND) | 352 | |
| Treatment Phase | STARTED | Cohort A, Arm C: BCG (IND+MNT) | 351 | |
| Treatment Phase | STARTED | Cohort B1: PF-06801591 300 mg | 5 | |
| Treatment Phase | STARTED | Cohort B2: PF-06801591 600 mg | 8 | |
| Treatment Phase | Treated | Cohort A, Arm A: PF-06801591+BCG (IND+MNT) | 350 | |
| Treatment Phase | Treated | Cohort A, Arm B: PF-06801591+BCG (IND) | 348 | |
| Treatment Phase | Treated | Cohort A, Arm C: BCG (IND+MNT) | 349 | |
| Treatment Phase | Treated | Cohort B1: PF-06801591 300 mg | 5 | |
| Treatment Phase | Treated | Cohort B2: PF-06801591 600 mg | 8 | |
| Treatment Phase | COMPLETED | Cohort A, Arm A: PF-06801591+BCG (IND+MNT) | 121 | |
| Treatment Phase | COMPLETED | Cohort A, Arm B: PF-06801591+BCG (IND) | 160 | |
| Treatment Phase | COMPLETED | Cohort A, Arm C: BCG (IND+MNT) | 203 | |
| Treatment Phase | COMPLETED | Cohort B1: PF-06801591 300 mg | 1 | |
| Treatment Phase | COMPLETED | Cohort B2: PF-06801591 600 mg | 4 | |
| Treatment Phase | NOT COMPLETED | Cohort A, Arm A: PF-06801591+BCG (IND+MNT) | 231 | |
| Treatment Phase | NOT COMPLETED | Cohort A, Arm B: PF-06801591+BCG (IND) | 192 | |
| Treatment Phase | NOT COMPLETED | Cohort A, Arm C: BCG (IND+MNT) | 148 | |
| Treatment Phase | NOT COMPLETED | Cohort B1: PF-06801591 300 mg | 4 | |
| Treatment Phase | NOT COMPLETED | Cohort B2: PF-06801591 600 mg | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04165317/flow